These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32838501)

  • 1. [Hemodynamic response in cirrhotic patients with transjugular intrahepatic portosystemic shunt].
    Wang JF; Ma JQ; Luo JJ; Chen HY; Mi SL; Chen SY; Su YG; Ge JB
    Zhonghua Nei Ke Za Zhi; 2020 Sep; 59(9):700-705. PubMed ID: 32838501
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: Relationship with diastolic dysfunction.
    Filì D; Falletta C; Luca A; Hernandez Baravoglia C; Clemenza F; Miraglia R; Scardulla C; Tuzzolino F; Vizzini G; Gridelli B; Bosch J
    Dig Liver Dis; 2015 Dec; 47(12):1052-8. PubMed ID: 26427586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.
    Huonker M; Schumacher YO; Ochs A; Sorichter S; Keul J; Rössle M
    Gut; 1999 May; 44(5):743-8. PubMed ID: 10205217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Management of Cirrhotic Cardiomyopathy.
    Kaur H; Premkumar M
    J Clin Exp Hepatol; 2022; 12(1):186-199. PubMed ID: 35068798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis.
    Busk TM; Bendtsen F; Poulsen JH; Clemmesen JO; Larsen FS; Goetze JP; Iversen JS; Jensen MT; Møgelvang R; Pedersen EB; Bech JN; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G275-G286. PubMed ID: 29074483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
    Lotterer E; Wengert A; Fleig WE
    Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt is associated with significant changes in mitral inflow parameters.
    Pudil R; Praus R; Hulek P; Safka V; Fejfar T; Vasatova M; Jirkovsky V
    Ann Hepatol; 2013; 12(3):464-70. PubMed ID: 23619264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.
    Rabie RN; Cazzaniga M; Salerno F; Wong F
    Am J Gastroenterol; 2009 Oct; 104(10):2458-66. PubMed ID: 19532126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular Intrahepatic Portosystemic Shunt: The Toulouse Algorithm.
    Billey C; Billet S; Robic MA; Cognet T; Guillaume M; Vinel JP; Péron JM; Lairez O; Bureau C
    Hepatology; 2019 Dec; 70(6):1928-1941. PubMed ID: 31512743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS).
    Merli M; Valeriano V; Funaro S; Attili AF; Masini A; Efrati C; De CS; Riggio O
    Am J Gastroenterol; 2002 Jan; 97(1):142-8. PubMed ID: 11808939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.
    Colombato LA; Spahr L; Martinet JP; Dufresne MP; Lafortune M; Fenyves D; Pomier-Layrargues G
    Gut; 1996 Oct; 39(4):600-4. PubMed ID: 8944572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
    Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
    Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the impact of cirrhotic cardiomyopathy on portal hemodynamics and survival after transjugular intrahepatic portosystemic shunt: a prospective study.
    Liu Y; Meng F; Ma J; Zhang W; Yu J; Zhou Y; Zuo W; Yan Z; Pan C; Luo J
    Abdom Radiol (NY); 2024 Oct; 49(10):3507-3516. PubMed ID: 38900326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of transjugular intrahepatic portosystemic stent shunt on systemic cardiocirculatory parameters.
    Saugel B; Mair S; Meidert AS; Phillip V; Messer M; Nennstiel S; Berger H; Gaa J; Wagner JY; Schneider H; Schmid RM; Huber W
    J Crit Care; 2014 Dec; 29(6):1001-5. PubMed ID: 25220530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced hemodynamic monitoring before and after transjugular intrahepatic portosystemic shunt: implications for selection of patients--a prospective study.
    Saugel B; Phillip V; Gaa J; Berger H; Lersch C; Schultheiss C; Thies P; Schneider H; Höllthaler J; Herrmann A; Schmid RM; Huber W
    Radiology; 2012 Jan; 262(1):343-52. PubMed ID: 22025732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.
    Wong F; Sniderman K; Liu P; Allidina Y; Sherman M; Blendis L
    Ann Intern Med; 1995 Jun; 122(11):816-22. PubMed ID: 7741365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cardiac effects of TIPS in cirrhotic patients with different "effective" blood volume.
    Salerno F; Cazzaniga M; Pagnozzi G; Cirello I; Nicolini A; Meregaglia D; Burdick L
    Hepatology; 2003 Dec; 38(6):1370-7. PubMed ID: 14647047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function.
    Van der Linden P; Le Moine O; Ghysels M; Ortinez M; Devière J
    Hepatology; 1996 May; 23(5):982-7. PubMed ID: 8621179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt in refractory ascites: clinical impact of left ventricular diastolic dysfunction.
    Debernardi Venon W; Lo Pumo S; Imperatrice B; Giorgi M; Righi D; Fonio P; Saracco GM; Marzano A
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e464-e470. PubMed ID: 33867443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on pulmonary and systemic hemodynamic changes after transjugular intrahepatic portosystemic shunt (TIPS)].
    Wagatsuma Y; Naritaka Y; Shimakawa T; Ogawa K
    Nihon Shokakibyo Gakkai Zasshi; 1998 Dec; 95(12):1350-6. PubMed ID: 9889543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.